Moyanova S, Kortenska L, Mitreva R
Bulgarian Academy of Sciences, Department of Neurobiology of Adaptation, Institute of Neurobiology, Sofia, Bulgaria.
Int J Neurosci. 2007 Sep;117(9):1361-81. doi: 10.1080/00207450600938847.
The long-term effects of the 5-HT(2A) receptor antagonist ketanserin on deficits in sensorimotor integration (limb placing tests) following transient focal cerebral ischemia in rats were compared to the effects of the NMDA antagonist MK-801. Middle cerebral artery occlusion was induced in conscious rats by microinjection of endothelin-1 in the vicinity of the artery (EMCAO model). The EMCAO/vehicle rats exhibited impaired tactile and proprioceptive limb placing. In contrast to ketanserin, MK-801 exerted severe early behavioral disturbances, but both drugs significantly improved the neurological scores much earlier than the spontaneous recovery of function occurred. The present results suggest that pharmacotherapy by means of ketanserin lacking the severe side effects of the NMDA antagonists can be used to enhance functional recovery after stroke.
将5-羟色胺(2A)受体拮抗剂酮色林对大鼠短暂局灶性脑缺血后感觉运动整合缺陷(肢体放置试验)的长期影响,与N-甲基-D-天冬氨酸(NMDA)拮抗剂MK-801的影响进行了比较。通过在动脉附近微量注射内皮素-1在清醒大鼠中诱导大脑中动脉闭塞(EMCAO模型)。EMCAO/载体大鼠表现出触觉和本体感觉肢体放置受损。与酮色林相反,MK-801产生严重的早期行为障碍,但两种药物都比功能自发恢复更早地显著改善了神经学评分。目前的结果表明,缺乏NMDA拮抗剂严重副作用的酮色林药物疗法可用于增强中风后的功能恢复。